Synovics Pharmaceuticals IncOver The Counter Market:SYVC
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Synovics Pharmaceuticals Inc | 3.0K | 0.0x | --- |
Gelesis Holdings Inc | 7.3K | 0.0x | --- |
Neurobiological Technologies Inc | 2.7K | 0.0x | --- |
cbdMD Inc | 1.8M | 0.0x | --- |
Sunshine Biopharma Inc | 5.2M | 0.0x | --- |
Cyanotech Corp | 3.8M | -0.7x | --- |
Company Information
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Contact Information
- Headquarters
- 5360 NW 35th AvenueFORT LAUDERDALE, FL, United States 33309
- Phone
- 954-486-4590
- Fax
- ---
Executives
- Chairman of the Board, Secretary
- Ronald Lane
- Interim Principal Executive Officer, Director
- Jyotindra Gange
- Chief Financial Officer
- Mahendra Desai
- VP - Business Development of Kirk Pharmaceuticals LLC
- John Copanos
- Director
- Maneesh Sapte
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.0K |
|---|---|
Revenue (TTM) | $19.1M |
Shares Outstanding | 29.8M |
Synovics Pharmaceuticals Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.17 |
Book Value | $0.18 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -22.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
